Quest Diagnostics Named "Most Admired Company"
News Feb 24, 2015
Quest Diagnostics has announced that it has been named a "Most Admired Company" by Fortune Magazine in the "Health Care: Pharmacy and Other Services" category.
"We are proud that Quest Diagnostics is included on FORTUNE's 2015 World's Most Admired Companies list in our category," said Steve Rusckowski, President and CEO. "The honor is a true team accomplishment, and my thanks and appreciation go to the 45,000 employees who empower better health care every day for the people we serve."
FORTUNE's list of Most Admired Companies is based on surveys of thousands of executives, directors and securities analysts based on nine criteria: innovation; people management; use of corporate assets; social responsibility; quality of management; financial soundness; long-term investment; quality of products and services; and global competitiveness.
The ranking for Quest Diagnostics may be found online at http://fortune.com/worlds-most-admired-companies/quest-diagnostics-100000/.
Most Admired Methodology
The survey employed by FORTUNE to designate its "World's Most Admired Companies" list assesses nine reputation drivers considered to be crucial to a company's global success including financial soundness, long-term investment value, people management, social responsibility, use of assets, quality of management, quality of products/services, innovation and global competitiveness.
These attributes were developed prior to the inception of the Most Admired Companies rankings in the mid-1980s through a series of interviews with executives and industry analysts to determine the qualities that make a company worthy of admiration.
Raters are asked to evaluate each eligible company on attributes by assigning a score from zero ('Poor') to ten ('Excellent'). For the purposes of the industry rankings, a company's overall score is determined through a simple average of the individual attribute scores. Companies who rank in the top half of their industry are defined as "most admired" within their industry.
Blood Test for Colitis Screening Could Reduce Dependence on ColonoscopyNews
A fast, simple blood test for ulcerative colitis using infrared spectroscopy could provide a cheaper, less invasive alternative for screening compared to colonoscopy, which is now the predominant test.READ MORE
Agilent Obtains U.S. FDA Approval for GenetiSure Dx Postnatal AssayNews
Agilent Technologies has obtained 510(k) clearance from the FDA for the GenetiSure Dx Postnatal Assay: its first comparative genomic hybridization (CGH) assay for diagnostic use.READ MORE
Endomag Receives CE Mark Approval for Magseed Breast Cancer Localisation TechnologyNews
Endomag can now use Magseed, an accurate marker for surgeons to use during breast cancer removal surgery.READ MORE
Comments | 0 ADD COMMENT
13th Edition of International Conference on Pediatric Gastroenterology
Aug 02 - Aug 04, 2018